Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 28;22(1):32.
doi: 10.1186/s10194-021-01224-8.

Medication overuse and drug addiction: a narrative review from addiction perspective

Affiliations
Review

Medication overuse and drug addiction: a narrative review from addiction perspective

Tatiane Teru Takahashi et al. J Headache Pain. .

Erratum in

  • Correction to: Medication overuse and drug addiction: a narrative review from addiction perspective.
    Takahashi TT, Ornello R, Quatrosi G, Torrente A, Albanese M, Vigneri S, Guglielmetti M, De Marco CM, Dutordoir C, Colangeli E, Fuccaro M, Di Lenola D, Spuntarelli V, Pilati L, Di Marco S, Van Dycke A, Abdullahi RA, van den Brink AM, Martelletti P; European Headache Federation School of Advanced Studies (EHF-SAS). Takahashi TT, et al. J Headache Pain. 2021 Jul 5;22(1):64. doi: 10.1186/s10194-021-01275-x. J Headache Pain. 2021. PMID: 34225669 Free PMC article. No abstract available.

Abstract

Chronic headache is particularly prevalent in migraineurs and it can progress to a condition known as medication overuse headache (MOH). MOH is a secondary headache caused by overuse of analgesics or other medications such as triptans to abort acute migraine attacks. The worsening of headache symptoms associated with medication overuse (MO) generally ameliorates following interruption of regular medication use, although the primary headache symptoms remain unaffected. MO patients may also develop certain behaviors such as ritualized drug administration, psychological drug attachment, and withdrawal symptoms that have been suggested to correlate with drug addiction. Although several reviews have been performed on this topic, to the authors best knowledge none of them have examined this topic from the addiction point of view. Therefore, we aimed to identify features in MO and drug addiction that may correlate. We initiate the review by introducing the classes of analgesics and medications that can cause MOH and those with high risk to produce MO. We further compare differences between sensitization resulting from MO and from drug addiction, the neuronal pathways that may be involved, and the genetic susceptibility that may overlap between the two conditions. Finally, ICHD recommendations to treat MOH will be provided herein.

Keywords: Dependence; Drug abuse; Migraine; Substance abuse; Vulnerability.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Simplified schematic of behaviors expressed by MO and drug addiction patients
Fig. 2
Fig. 2
Simplified summary of changes produced by repeated administration of triptans or analgesics
Fig. 3
Fig. 3
Simplified neuroimaging findings that overlap for MO and drug addiction

References

    1. G.B.D.H Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):954–976. doi: 10.1016/S1474-4422(18)30322-3. - DOI - PMC - PubMed
    1. Steiner TJ, et al. Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. doi: 10.1186/s10194-020-01208-0. - DOI - PMC - PubMed
    1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 2018. 38(1): p. 1–211 DOI: 10.1177/0333102417738202 - PubMed
    1. May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–464. doi: 10.1038/nrneurol.2016.93. - DOI - PubMed
    1. Negro A, Rocchietti-March M, Fiorillo M, Martelletti P. Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci. 2011;15(12):1401–1420. - PubMed

MeSH terms